PHARMING

Pharming is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life threatening diseases. Pharming is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patient... Pharming is headquartered in Leiden, the Netherlands with its U.S. headquarters located in Warren, New Jersey. Pharming is dually listed on the Euronext Amsterdam (PHARM) and Nasdaq (PHAR) exchanges... Pharming's vision is to become the leading global rare disease company of choice for patients and partners with a specific focus on transformative medicines in rare diseases. Our mission is to bring the unserved rare disease patients the solutions they need through our fully integrated and ongoing clinical development and commercialization expertise. Our core values enable our mission and create a clear pathway forward to meet our strategic goals and objectives.

Also known as: Pharming Group, Pharming Group N.V.

Primary location: Leiden Netherlands